All In MedTech

Device Trial Radar · NCT04075591

Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Post-approval Study of Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia

Last checked: Nov 20, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

219

Actual

Start

Sep 24, 2019

Primary completion

Jun 25, 2025

Study completion Jun 25, 2025

Sponsor

Lead sponsor
AMO Development, LLCNot on our public-company list
Sponsor type
Industry
First posted
Aug 30, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be a 12-month, prospective, multicenter, open-label, non-comparative, non-randomized clinical investigation conducted at 8 to 14 sites. A total of 383 subjects will be enrolled to achieve approximately 268 treated subjects, resulting in at least 241 evaluable subjects at the point of refractive stability. After signing the informed consent, subjects meeting all inclusion and exclusion criteria in both eyes may be scheduled for surgery. The follow-up visit schedule will be the same for each operative eye.

Conditions

  • Refractive Error

Interventions

  • iDesign Refractive Studio with STAR S4 IR® Excimer laser SystemDevice

    Surgeons will perform wavefront-guided monovision LASIK for the treatment of myopic subjects with presbyopia based upon measurements obtained with an iDesign Refractive Studio.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Driving Scale Score From Preoperative to Postoperative as Measured by Driving Scale Within Patient-Reported Outcomes With LASIK for Monovision (PROWL-M)Time frame: From preoperative (within 120 to 14 days prior to surgery on Day 0) to 12 month postoperative (operated on Day 0)
  2. Percentage of Participants Who Required Secondary Surgery to Reverse MonovisionTime frame: At 12 month postoperative (operated on Day 0)

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Maloney Vision Institute

    Los Angeles, California

  • Kraff Eye Institute

    Chicago, Illinois

  • Center for Sight

    Las Vegas, Nevada

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.